18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma

BACKGROUND: Clinical data that support stereotactic body radiation therapy (SBRT) metastatic malignant melanoma (MM) are limited. Furthermore, functional imaging with 18F-fludeoxyglucose positron emission tomography (PET) may offer a more accurate post-SBRT assessment. Therefore, we assessed the cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Youland, Ryan S., Packard, Ann T., Blanchard, Miran J., Arnett, Andrea L., Wiseman, Gregory A., Kottschade, Lisa A., Dronca, Roxana S., Markovic, Svetomir N., Olivier, Kenneth R., Park, Sean S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514257/
https://www.ncbi.nlm.nih.gov/pubmed/28740933
http://dx.doi.org/10.1016/j.adro.2017.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514257/
https://www.ncbi.nlm.nih.gov/pubmed/28740933
http://dx.doi.org/10.1016/j.adro.2017.02.003

Ejemplares similares